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ABSTRACT
Medical devices that utilize computer software are becoming common place in today’s health care
environment. In this paper we examine device failures in the area of the human computer interaction—a
failure of the interface between the hardware/software in the medical device, and the person using the
device. We make the case that human computer interaction testing—starting early on in the product
development life cycle—should be required before medical devices are approved by the FDA. Use of
human computer interaction testing of medical devices can improve device quality and user experience,
and most importantly, has the potential to reduce serious health care outcomes.

INTRODUCTION
Medical devices that utilize computer software are becoming common place in today’s health
care, ranging from insulin pumps, to devices that dispense drugs, and those that monitor heart
rhythms. Many medical devices have been used successfully to provide better patient care, often
with costs savings, and in most situations actually address some areas of human driven errors
(Berman, 2004).
At the same time software to program and/or control medical devices can, and have, introduced
errors that affect patient outcomes. The errors are in part due to the software or a failure of the
interface between the hardware and software in the medical device, and the person using the
device. Errors in medical devices raise questions concerning the strength of the design and
testing of human computer interactions when developing medical devices. Sufficient human
computer interface testing should ensure that most errors are identified before products are
released.
The FDA has an approval process for medical devices with differences depending on the
criticality level of the application of the medical devices. It appears that human computer
interaction testing is not a clearly required component of the FDA medical device approval
process. We believe that human computer interaction testing should be required before medical
devices are approved by the FDA. The challenge is in specifying criteria to help a manufacturer
determine what is “sufficient” human computer interaction testing.

Communications of the IIMA

57

2009 Volume 9, Issue 2

Integrating Human Computer Interaction into the Medical Device Approval Process Nindel-Edwards & Steinke

Medical Device Failures
A few examples of problems with the human computer interface of medical devices will provide
some background for this paper.
The Therac-25 device was developed to provide radiation to cancer patients. The presence of
numerous flaws in the software led to massive radiation overdoses, resulting in the deaths of
three people (Leveson, 1993). It was poor user interface controls that caused prescription and
dose rate information to be entered improperly (McQuaid, 2009).
A problem with a flow control knob is cited by the FDA (Sawyer, 1996): "A physician treating a
patient with oxygen set the flow control knob between 1 and 2 liters per minute, not realizing
that the scale numbers represented discrete rather than continuous, settings. There was no oxygen
flow between the settings, yet the knob rotated smoothly, suggesting that intermediate settings
were possible. The patient, an infant, became hypoxic before the error was discovered. Human
computer interaction testing of this device should have identified this problem."
A volumetric infusion pump is a medical device that delivers intravenous fluids and medicine to
patients. The Baxter Colleague triple channel infusion pump generates fault codes under the
condition of changing a fluid supply at the same time the supply goes to zero (an understandable
and appropriate behavior). Unfortunately this fault also stopped the other two channels from
continuing to operate, causing a life threatening situation for patients. At least 9 patients’ deaths
have been attributed to miscommunication between the care giver and the software that runs
these medical devices (Infusion Pump Recall, 2009).
The Journal of the American Medical Association (Koppel, Metlax, Cohen, Aboluck, Localio,
Kimmell, & Strom, 2005) reported on an examination of a hospital computer system and
suggested that computers increased the error risk. They said, “…the problem is that hospital
computer systems are not designed for the way real-life hospitals work.” It appears that their
recommendation is for more human computer interaction testing.
Further examples can be found in an article published by Dick Sawyer (1996). And the
complexity of user - computer interaction is growing: The deployment of medical devices to the
field such that "Caregivers and clinical engineers ... are becoming lost in a swirl of technology,
and [we] face unanticipated interference between devices" (Lee & Pappas, 2006). It is clear that
some medical devices have failed, at least in part due to the software in the devices.
Human Computer Interaction Testing
When there is an accident involving computers, Marc Green says, “First, the computer interface
should be evaluated for adequacy of design. Faulty design could be construed as negligence on
the part of the designers”.
Human computer interaction testing is being commonly used in many commercial settings to
form better human computer interface scenarios (Gosbee & Ritchie, 2007). Popular software
developed by organizations such as Microsoft and Adobe, as well as web site applications are
expected to be tested for human computer interaction. Similar to human factors engineering
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used in building non-computerized devices, interaction design can be extremely valuable to hone
in on robust command and control of medical devices used to supply care to patients (Sawyer,
1996). The requirement for medical device manufacturers to adopt the use of interaction design
in the development of medical devices could – literally – be a life saving event.
The users of medical devices are both patients and medical professionals. This means the human
computer interaction testing needs to include both types of users. Patients come with all levels
of background and experience with technology. Medical professionals naturally are very patient
focused, not necessarily medical device focused. Human computer interaction testing needs to
meet the needs of all potential users.
FDA Standards for medical devices
The Federal Drug Administration has established standards for medical devices and classifies
these based on criticality levels of the device usage, ranging from Class I (least critical) to Class
III (life support/life sustaining) (FDA, 2006):
•
•
•

Class I – Devices used in non-life sustaining tasks, subject only to “General
Controls”.
Class II – Also non-life sustaining, but subject to both “General Controls” and
“Special Controls” (FDA, 2006a).
Class III – Devices that sustain or support life, subject to both types of controls and
may not be introduced to market without FDA oversight and pre-approval requiring
in many cases clinical trials.

Class III medical devices require the most scrutiny, and accordingly are the devices that cost the
most to develop, test, and support. It is interesting to note that Class II devices can, and are,
applied in situations where if not used, or tested appropriately, can result in serious injury and
possible patient mortality. And yet the approval process for Class II is significantly reduced
from Class III devices. Also, from the FDA perspective, it seems that the difference between
hardware and computer controls with associated software is not material. The devices are simply
classified as I, II, or III, based on usage. Perhaps the testing could also be based on the
complexity of the device and the associated software—the more complex, the more testing
should be required.
FDA Recommendation for software development
There are software standards published by the FDA in 2002 that provide guidelines and
requirements for the software used in medical devices, regardless of class (Quality System
Regulation, 2006). Various FDA documents specify that the “general controls” associated with
software in medical devices follow existing standards for requirement driven software projects,
e.g. the classic waterfall model overlaid by a risk based analysis termed “Level of Concern”.
This is summarized in the Guidance for the Content of Premarket Submissions for Software
Contained in Medical Devices documented in the following decision matrix (FDA, 2006):
The criticality of devices is divided into three classes: Class I, II and III. The software is
divided into three areas as well: Minor Concern, Moderate Concern and Major Concern (see
Table 1). There is some relationship between the two. That is to say that a medical device could
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be a class III (highest standards) yet the software associated with the device be only a "minor
concern" if the software component was actually peripheral to the Class III rating. This in fact
was the situation with the first model of the Therac as the hardware provided the protection and
the associated software was of "moderate concern". When the hardware interlock was removed
the software moved from "moderate" to "major" without the appropriate review of the software
component.
Table 1: Software documentation.
SOFTWARE
DOCUMENTATION

MINOR CONCERN

MODERATE CONCERN MAJOR CONCERN

Level of Concern

A statement indicating the Level of Concern and a description of the rationale for
that level.

Software Description

A summary overview of the features and software operating environment.

Device Hazard Analysis

Tabular description of identified hardware and software hazards, including severity
assessment and mitigations.

Software Requirements
Specification (SRS)

Summary of functional
requirements from SRS.

The complete SRS document.

Architecture Design Chart

No documentation is
necessary in the
submission.

Detailed depiction of functional units and software
modules. May include state diagrams as well as flow
charts.

Software Design
Specification (SDS)

No documentation is
necessary in the
submission.

Software design specification document.

Traceability Analysis

Traceability among requirements, specifications, identified hazards and
mitigations, and Verification and Validation testing.

Software Development
Environment Description

No documentation is
necessary in the
submission.

Verification and Validation
Documentation

Software functional test
Description of V&V
plan, pass / fail criteria, and activities at the unit,
results.
integration, and system
level. System level test
protocol, including pass/fail
criteria, and tests results.

Revision Level History

Revision history log, including release version number and date.

Summary of software life
cycle development plan,
including a summary of the
configuration management
and maintenance activities.

Summary of software life
cycle development plan.
Annotated list of control
documents generated
during development
process. Include the
configuration
management and
maintenance plan
documents.
Description of V&V
activities at the unit,
integration, and system
level. Unit, integration
and system level test
protocols, including
pass/fail criteria, test
report, summary, and tests
results.

Unresolved Anomalies (Bugs No documentation is
necessary in the
or Defects)
submission.

List of remaining software anomalies, annotated with
an explanation of the impact on safety or
effectiveness, including operator usage and human
factors.
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The key reports associated with the FDA specifications are listed in the first column above:
•
•
•
•
•
•
•
•

Software Requirements Specification (SRS),
Architecture Design Chart,
Software Design Specification (SDS),
Traceability Analysis,
Software Development Environment Description,
Verification and Validation Documentation,
Revision Level History, and
Defect Reports.

The key deliverable is the Verification and Validation (aka V&V) documentation. While a
common term in the software industry, we’ll reflect here on the FDA’s definition (FDA, 2002):
•

Software verification provides objective evidence that the design outputs of a
particular phase of the software development life cycle meet all of the specified
requirements for that phase. Software verification looks for consistency,
completeness, and correctness of the software and its supporting documentation, as it
is being developed, and provides support for a subsequent conclusion that software is
validated. Software testing is one of many verification activities intended to confirm
that software development output meets its input requirements. Other verification
activities include various static and dynamic analyses, code and document
inspections, walkthroughs, and other techniques.

•

Software validation is a part of the design validation for a finished device, but is not
separately defined in the Quality System regulation. The FDA considers software
validation to be "confirmation by examination and provision of objective evidence
that software specifications conform to user needs and intended uses, and that the
particular requirements implemented through software can be consistently fulfilled."
In practice, software validation activities may occur both during, as well as at the end
of the software development life cycle to ensure that all requirements have been
fulfilled. Since software is usually part of a larger hardware system, the validation of
software typically includes evidence that all software requirements have been
implemented correctly and completely, and are traceable to system requirements. A
conclusion that software is validated is highly dependent upon comprehensive
software testing, inspections, analyses, and other verification tasks performed at each
stage of the software development life cycle. Testing of device software functionality
in a simulated use environment, and user site testing are typically included as
components of an overall design validation program for a software automated device.

An interesting point here is the statement “that software specifications conform to user needs and
intended uses”. This assumes that the Software Requirements Specifications (SRS) in and of
itself is correct, and Verification and Validation (V&V) assures the device software matches the
specifications. What if the SRS itself is flawed in one or more areas? The very best we can say
is that we’ve assured (through the V&V process) that the software perform well to the
requirements (SRS) without highlighting the underlying flaw in the SRS.
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So we have two areas to examine:
•
•

Does the software perform according to the requirements?
Are the requirements indeed accurate and complete?

It seems obvious that the latter question should be addressed first. The software quality
assurance perspective on this problem is to “drive quality upstream” by verifying the correctness
of the requirements, in this instance the SRS and Software Design Specification (SDS). Then the
Verification and Validation process can assure that the system meets requirements which have
also been tested.
Recommendation: Include Interaction Design Testing in the Development of FDA Approved
Devices
The techniques to ensure the requirements are accurate and complete is human factor based
design and its counterpart in the software world: human computer interaction design. Driving
quality “upstream” would suggest that we require that both human factors analysis (hardware)
and interaction design (software) techniques be used not only in the V&V of medical devices,
but even earlier in the development of these devices. The software perspective suggests that
examining the device and software interface before the device is deployed can identify problems
before a device is released to market.
Human computer interaction design can even be a potential advantage to the speed of
development and deployment of medical devices as software, by its very nature, can be more
easily adapted in the development process than hardware devices. Human computer interaction
design call for creating prototypes of human computer interfaces and then testing them for
usability. This approach can directly address two of the challenges associated with complex
medical devices software, especially the use of "Model Based Development", and User-Centered
Design (Lee & Pappas, 2006). Leaving user-computer interaction to the V&V phase to catch
design problems suggests that the traditional design techniques are adequate to cover all Human
Computer Interaction (HCI) problems, yet the evidence belies that assumption. The use of
Interaction Design techniques directly addresses some of the important and even life critical,
issues. Having improved (a quality measurement) the initial human device interface the V&V
effort can then focus on whether the device is fulfilling its mission.
The only mention of human factors in the FDA’s guidance document (FDA, 2002) relates to
"Unresolved Anomalies" (e.g. defects). The recommendation does not include the use of either
human factors or interaction design early in the hardware/software development effort—the very
place where the payback is the greatest. The critical step of giving instructions (some would say
programming) the devices to dispense critical care is essential to the effective use of these
devices. This is the role of the human machine interface, both in the “programming” of the
device and the feedback given from the device to the human, both to “understand” the
instructions, and the on-going “status” reporting that the “instructions” are being followed.
Making certain that the human computer interaction is an accurate and safe experience is a
reflection of a high quality medical device.
Medical devices put a heavy responsibility on the design team responsible for the development
and implementation of medical devices. The medical device design teams is not are not licensed
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care givers but computer hardware, and software developers. Theirs is the job of both discerning
not only the requirements and anticipated uses of medical devices, but the potential for boundary,
outlier, and simply misuse of these devices. It is worthwhile to repeat Marc Green’s comment:
“Faulty design could be construed as negligence on the part of the designers.”
The goal of interaction design, and its associated testing, is to verify at the start of the design
phase the usability of the yet-to-be built software. Concentrating on what, and how, a critical
heath care application is intended to respond is certainly a factor in the development and delivery
of functionality. Interaction design and its associated "testing" of medical device performance
can assure that the device delivers its critical care under the anticipated circumstances and
continues to delivers critical care when circumstances are less than ideal. Any of us can suggest
that if events had only gone as we expected them to unfold, everything would "be ok".
Interaction design allows us to "what if" the unexpected happens and test whether the systems
(device plus actor) respond appropriately.
A challenge for the FDA as well as a medical device manufacturer is the question: What is
appropriate and sufficient testing? How much testing is enough? Often it is impossible to test
all possible conditions and situations. Certainly the testing should relate to the FDA’s definition
of Class I, II and III devices. Perhaps there should also be some factor as to the complexity of
the software in a particular device, with more complex software functions calling for more
testing. We would also suggest that an independent organization verify the testing performed by
the manufacturer and provide some level of certification as to the testing that has been
performed.
CONCLUSION
Human computer interaction has been successfully used in many commercial settings to form
better human computer interface scenarios. Similar to human factors engineering used in
building non-computerized devices, human computer interaction design testing can be extremely
valuable to hone in on robust command and control of medical devices used to supply critical
care to patients. The FDA should require medical devices manufacturers to test the interaction
design during the development of medical devices. In addition, we suggest an independent
certification for human computer interaction testing. Further research is necessary to determine
certification levels and their relationship to the criticality levels of the medical devices.
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